Nachrichten zur Eli Lilly & Co. Aktie

Is the Trump Administration About to Cause AbbVie, Eli Lilly, and Johnson & Johnson Stocks to Crash?

Investors often view Pharmaceutical stocks as safe havens during periods of market turbulence. Stock market volatility or even economic downturns…

Eli Lillys Meltdown Triggers Near Doubling Upside Potential - Reiterate Buy

…

Eli Lilly: Dont Overthink This Buying Opportunity

…

Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday

GLP-1 drug prices are falling. Thats good news for patients, but perhaps not such good news for pharmaceutical stock investors.…

Is Novo Nordisk Stock a Buy?

For years, Denmark-based Novo Nordisk (NYSE: NVO) was a fairly traditional develop-and-market pharmaceutical company that escaped notice by many investors.…

Novo Nordisk Forges Multiple Partnerships To Sell Obesity Drug Wegovy At A Discount

The pharmaceutical firm Novo Nordisk is pursuing a multi-pronged strategy to regain market share that it has lost to Eli…

Eli Lillys earnings beat is clouded by Novo news. What it means for investors

We suspect the CVS Health change, which goes into effect on July 1, could put a temporary overhang on Eli…

CVS Health Excludes Zepbound: Why Eli Lillys 11%+ Drop Looks Overdone

…

Stocks making the biggest moves midday: Meta Platforms, Qualcomm, Eli Lilly, CVS Health and more

These are the stocks posting the largest moves in midday trading.…

Why Eli Lilly Stock Is Sinking Today

Shares of Eli Lilly (NYSE: LLY) are sliding on Thursday. The stock lost 8.3% as of 12:21 p.m. ET. The…

5 stocks to watch on Thursday: AAPL, ABNB, MA, LLY and MCD (MA:NYSE)

Apple (AAPL), Airbnb (ABNB), Mastercard (MA), Eli Lilly (LLY), and McDonalds (MCD) are the stocks to watch on Thursday. Read…

Eli Lilly CEO says company can help respond to national security concerns around essential drugs as tariffs loom

Ricks said reshoring manufacturing capacity for older essential medicines is "a valid thing," adding that Eli Lilly is "happy to…

US-Pharmakonzern Eli Lilly senkt Gewinnprognose wegen Abschreibungen

INDIANAPOLIS (dpa-AFX) - Der US-Pharmahersteller Eli Lilly hat wegen Abschreibungen auf einen Zukauf seine Gewinnerwartung…

Eli Lilly sales soar 45% on weight loss drug demand, but drugmaker cuts profit outlook after cancer treatment deal

Eli Lilly said sales of weight loss drug Zepbound and diabetes treatment Mounjaro soared in the first quarter.…

Eli Lilly posts strong Q1 results, but weight-loss drug sales disappoint

Eli Lilly on Thursday posted better-than-expected first quarter revenue and profit, although sales of its popular weight-loss drug, Zepbound, came…

Eli Lilly shares slide despite weight-loss drug boost as company trims 2025 profit outlook

Eli Lilly and Co (NYSE:LLY) shares fell as much as 7.7% at the open on Thursday after the drugmaker cut…

1 Beaten-Down Stock to Buy and Hold for 10 Years

Viking Therapeutics (NASDAQ: VKTX) was one of the hottest biotech stocks of 2024; its shares soared last year following excellent…

1 Beaten-Down Stock That Could Skyrocket By 321%, According to Wall Street

Equity markets have been volatile this year due to macroeconomic and geopolitical factors. Many of the worlds largest corporations havent…

Novo Nordisk strikes telehealth deals for obesity drug, following Eli Lilly

Novo is expanding its direct-to-consumer efforts around its obesity drug Wegovy, partnering with telehealth companies…

CEOs from Nividia, J&J and Eli Lilly to join Trumps "Invest in America" event at White House

Trumps tariffs threats have left the countrys status as the top global investment magnet in doubt.…

Trump to tout US investments from Nvidia, J&J, Hyundai, Toyota

CEOs and other executives from Nvidia , Johnson & Johnson , Toyota Motor , Eli Lilly and SoftBank Group are…

Trump to Tout US Investments From Nvidia, J&J, Hyundai, Toyota

By David Shepardson WASHINGTON (Reuters) -CEOs and other executives from Nvidia, Johnson & Johnson, Toyota Motor, Eli Lilly and SoftBank…

Nvidia, Eli Lilly Among CEOs to Tout US Investments With Trump

Chief executive officers from Nvidia Corp., Johnson & Johnson, Eli Lilly & Co., General Electric Co. and SoftBank Group Corp.…

Eli Lilly: Why Orforglipron Matters, A Lot

…

HSBC downgrades Eli Lilly over valuation worry and strong competition

Shares have advanced about 15% in 2025.…

Stocks making the biggest moves premarket: Boeing, Dominos Pizza, Eli Lilly, Progressive and more

These are the stocks posting the largest moves in premarket trading.…

Is Eli Lilly Stock a Portfolio Must-Have Pre-Q2 Earnings?

Investor focus is likely to be on the sales numbers of LLYs tirzepatide medicines Mounjaro and Zepbound.…

Is Eli Lilly Stock a Portfolio Must-Have Pre-Q1 Earnings? (Revised)

Investor focus is likely to be on the sales numbers of LLYs tirzepatide medicines Mounjaro and Zepbound.…

The Best Stock to Buy With Less Than $60 in the Market Sell-Off

Plenty of stocks with attractive businesses trade on the market for hundreds of dollars per share -- or more. However,…

Eli Lilly (LLY) Earnings Expected to Grow: What to Know Ahead of Next Weeks Release

Lilly (LLY) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming…

Massive Investment in US Manufacturing Triggers Wave of Career Opportunities

Companies are announcing significant investments in U.S. manufacturing in response to looming tariffs. An AstraZeneca executive and Eli Lilly and…

Forget Zepbound: Eli Lilly Has Its Next Billion-Dollar Weight Loss Drug

Eli Lilly (NYSE: LLY) has been growing its sales at a good clip over the past year. This is partly…

Stocks making the biggest moves premarket: Boeing, Tesla, BP, Eli Lilly and more

These are the stocks posting the largest moves in premarket trading.…

Is Eli Lilly Stock Going to $900? 1 Wall Street Analyst Thinks So.

Rather counterintuitively, following some promising news about a pipeline drug, one analyst tracking Eli Lilly (NYSE: LLY) stock cut his…

Eli Lilly sues four telehealth sites selling compounded Zepbound, Mounjaro

Eli Lilly & Co. is suing four telehealth companies selling compounded versions of Lillys weight-loss drug Zepbound and its diabetes…

Eli Lilly (LLY) Ascends But Remains Behind Market: Some Facts to Note

Eli Lilly (LLY) closed at $827.54 in the latest trading session, marking a +1.16% move from the prior day.…

3 Relatively Safe Healthcare Growth Stocks You Can Buy and Hold

When the stock market is highly volatile, many investors flock to assets that offer stability but dismal growth prospects. However,…

These companies have announced their intention to increase US manufacturing

Numerous companies have unveiled investments in U.S. manufacturing in recent weeks, including TSMC, Eli Lilly, Hyundai Motor Group and others.…

Eli Lilly im Pivotal-Point-Check: Abnehmpille feiert Studienerfolg - Nadelfreie Revolution für Gewichtsverlust und Diabetes!

Eli Lilly ist der Top-Profiteur nadelfreier Alternativen auf dem boomenden Markt für Gewichtsverlust und Diabetes. Veröffentlichung der Studiendaten zu…

dpa-AFX ProFeed